Anti-Retroviral drugs Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast The global anti-retroviral drugs market size is expected to expand at a robust CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the rising burden of HIV, increasing investment in research and development and growing demand for of new and efficient drugs.
Antiretroviral drugs (ARV) are used to treat HIV. Approximately 37.9 million people worldwide are infected with HIV/AIDS. In 2018, an estimated 1.7 million people worldwide were infected with HIV. For unstable HIV strains, antiretroviral therapy can inhibit about 80% of HIV replication.
Market Trends, Drivers, Restraints, and Opportunities
Increasing incidence of HIV is expected to boost the market growth during the forecast period. Rapid growth of the healthcare industry is one of the major factors boosting the market growth in the coming years. Increasing geriatric population and availability of products being developed for the treatment of HIV are anticipated to drive the market growth during forecast period. High price of anti-retroviral drugs and presence of generic drugs are expected to hamper the market growth. Rising awareness about drugs treatment and initiatives taken by government and other nonprofit organizations by launching educational programs can proliferate the growth of the market. Rising R&D investment and ongoing development of new efficient drugs to reduce the therapy cost are expected to create immense opportunities for the market players in the projected timeline.